These Form 3 filings are administrative and provide no trading signal. Monitor future Form 4 filings for insider transactions that could indicate management's view of the stock.
Price Chart
Executive Summary
Odyssey Therapeutics filed two Form 3 initial beneficial ownership statements for new insiders Ourania Tatsis and Valerie Odegard, disclosing stock option grants with exercise prices between $3.98 and $5.15 per share. These are routine filings with no material impact on the company's financials or operations.
Key Facts
- Ourania Tatsis received an option to purchase 196,497 shares at $4.18, vesting over 4 years.
- Valerie Odegard holds multiple options totaling approximately 196,493 shares at exercise prices ranging from $3.98 to $5.15.
- Both filings are initial statements of beneficial ownership, required when becoming a reporting insider.
Financial Impact
No financial impact; options are compensatory and subject to vesting.
Risk Factors
- No material risks identified from these filings.
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (ODTX) — Batch item 1 | 0001193125-26-212880 |
| Document: 0001193125-26-212880-index-headers.html | 0001193125-26-212881 |
| Document: 0001193125-26-212880-index.html | 0001193125-26-212880 |
| Document: 0001193125-26-212880.txt | 0001193125-26-212880 |
| 3 Filing (ODTX) — Batch item 5 | 0001193125-26-212881 |
| Document: 0001193125-26-212881-index-headers.html | 0001193125-26-212880 |
| Document: 0001193125-26-212881-index.html | 0001193125-26-212880 |
| Document: 0001193125-26-212881.txt | 0001193125-26-212880 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $18.99 $19.00 | ▲ +0.05% | ▼ −0.47% | $19.30 (+1.63%) |
Aug 4, 2026 11w ago | 8-K | $19.96 $20.89 | ▲ +4.66% | ▲ +4.86% | $19.30 (−3.31%) |
Jun 17, 2026 18w ago | 8-K | $19.07 $18.72 | ▼ −1.84% | ▼ −1.52% | $19.30 (+1.21%) |
May 11, 2026 24w ago | Insider Cluster | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.30 (+10.60%) |
May 8, 2026 24w ago | 424B4 | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.30 (+10.60%) |
May 8, 2026 24w ago | EFFECT | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers